ORIGINAL ARTICLE


Open Access Peer-Reviewed

0

View

The prevalence of schizophrenia in Brazil: social vulnerability as a key consideration for care and policy

Ary Gadelha1,2*, Carolina Ziebold2*, Pedro Gabriel Lorencetti1,2, Naielly Rodrigues da Silva2, Alexandre Faisal-Cury3, Daniel Mauricio de Oliveira Rodrigues3,4,5, Christoph U. Correll6,7,8,9,10,11,12, Jair Mari13, Russell Margolis14,15, Raffael Massuda16

DOI: 10.47626/1516-4446-2025-4437

Epub: November 6 2025

Braz J Psychiatry. 2026;48:e20254437

1. Programa de Esquizofrenia, Departamento de Psiquiatria, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
2. Laboratório Interdisciplinar de Neurociências Clínicas, EPM, UNIFESP, São Paulo, SP, Brazil
3. Departamento de Medicina Preventiva, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil
4. Departamento de Ciências Biológicas e da Saúde, Universidade do Sul de Santa Catarina, Palhoça, SC, Brazil
5. Departamento de Ciências da Saúde, Universidade Cruzeiro do Sul, São Paulo, SP, Brazil
6. Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA
7. Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA
8. Center for Psychiatric Neuroscience, The Feinstein Institute for Medical Research, Northwell Health, New Hyde Park, NY, USA
9. Department of Child and Adolescent Psychiatry, Charité – Universitätsmedizin Berlin, Berlin, Germany
10. German Center for Mental Health, Partner Site Berlin, Berlin, Germany
11. German Center for Child and Adolescent Health, Partner Site Berlin, Berlin, Germany
12. Einstein Center for Population Diversity, Berlin, Germany
13. Departamento de Psiquiatria, UNIFESP, São Paulo, SP, Brazil
14. Division of Neurobiology, Department of Psychiatry, Schizoaffective Disorder Precision Medicine Center of Excellence, Johns Hopkins University School of Medicine, Baltimore, MD, USA
15. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
16. Departamento de Psiquiatria, Universidade Federal do Paraná, Curitiba, PR, Brazil

* These authors contributed equally to this study.

Corresponding author

Ary Gadelha, Laboratório
Interdisciplinar de Neurociências Clínicas, Escola Paulista de Medicina, Universidade Federal de São Paulo
Rua Pedro de Toledo, 669, 3º andar
CEP 04039-032, São Paulo, SP, Brazil
E-mail: aryararipe@yahoo.com.br


© 2026 All rights reserved